(Q38859067)

English

How Much Surface Coating of Hydrophobic Azithromycin Is Sufficient to Prevent Moisture-Induced Decrease in Aerosolisation of Hygroscopic Amorphous Colistin Powder?

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

How Much Surface Coating of Hydrophobic Azithromycin Is Sufficient to Prevent Moisture-Induced Decrease in Aerosolisation of Hygroscopic Amorphous Colistin Powder? (English)

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

0 references

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

object named as

John A Denman

6

0 references

object named as

Jian Li

7

0 references

author name string

Qi Tony Zhou

1

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Zhi Hui Loh

2

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Jiaqi Yu

3

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Si-Ping Sun

4

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Thomas Gengenbach

5

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

language of work or name

0 references

publication date

2 June 2016

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

The AAPS Journal

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

18

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

5

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

1213-1224

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Development of Liposomal Ciprofloxacin to Treat Lung Infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Powder Production and Particle Engineering for Dry Powder Inhaler Formulations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Inhaled formulations and pulmonary drug delivery systems for respiratory infections.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Inhaled antimicrobial therapy - barriers to effective treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Emerging inhalation aerosol devices and strategies: where are we headed?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Pulmonary and systemic pharmacokinetics of inhaled and intravenous colistin methanesulfonate in cystic fibrosis patients: targeting advantage of inhalational administration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Synergistic antibiotic combination powders of colistin and rifampicin provide high aerosolization efficiency and moisture protection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

A critical view on lactose-based drug formulation and device studies for dry powder inhalation: which are relevant and what interactions to expect?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Delivery of antibiotics to the respiratory tract: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Pharmaceutical particle engineering via spray drying

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

The influence of relative humidity on particulate interactions in carrier-based dry powder inhaler formulations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

In vitro antimicrobial synergy studies of carbapenem-resistant Acinetobacter baumannii isolated from intensive care units of a tertiary care hospital in Egypt

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Colistin resistance: a major breach in our last line of defence.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

25 September 2017

Comment on: inhaled antimicrobial therapy--barriers to effective treatment, by J. Weers, inhaled antimicrobial therapy - barriers to effective treatment, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

25 September 2017

Colistin powders with high aerosolisation efficiency for respiratory infection: preparation and in vitro evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

22 August 2018

The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

22 August 2018

How much particle surface corrugation is sufficient to improve aerosol performance of powders?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

22 August 2018

Characterization of the surface properties of a model pharmaceutical fine powder modified with a pharmaceutical lubricant to improve flow via a mechanical dry coating approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/27255350

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physicochemical aspects of the coformulation of colistin and azithromycin using liposomes for combination antibiotic therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/27255350

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Investigating the interactions of amino acid components on a mannitol-based spray-dried powder formulation for pulmonary delivery: A design of experiment approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/27255350

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lactose as a carrier for inhalation products: breathing new life into an old carrier. Preface

1 reference

https://pubmed.ncbi.nlm.nih.gov/27255350

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Large porous particles for pulmonary drug delivery

1 reference

https://pubmed.ncbi.nlm.nih.gov/27255350

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1208/S12248-016-9934-X

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38859067&oldid=2202189520"